Seated group applauding


Taxonomy Icon
Dr. Mehta Presents at the 3rd Annual Glioblastoma Drug Development Summit
  • Jan 19, 2022
  • 9:25 - 10:00am
Dr. Shwetal Mehta, will be participating in an open discussion of the limitations of current drug development for GBM and where the field Can improve. As the Chief Operating Officer of the Ivy Brain Tumor Center, Dr. Mehta plays a crucial role in the work being done at the world-renowned Phase 0 clinical trials program.